Concepedia

Y Zhang

YZ

1

Publications

72

Citations

1

H-Index

2017

Active since

Affiliations

Eli Lilly (United States)(Current)

Y Zhang is an author at Eli Lilly (United States) specializing in cell biology, tumor biology, and cancer research.

Top concepts

MedicineOncologyCell BiologyPharmacologyTumor BiologyCancer BiologyCancer Research

Publications per year

2017–2017

1

Publications

1

RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1

S-H Chen, Xutong Gong, Y Zhang et al. · Oncogene · 2017 · 72 citations

Tumor Biology, Cdk4/6 Inhibition, Cyclin D1 +9

Rows per page

1–1 of 1